Notificação de entrada na fase nacional - PCT
#1.3
03/31/2026
RPI 2882
Application data
Number
112025011202Type
Filing
Publication
PCT
US2023083039 Examination has not been requested yet. Without that request by 12/08/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:12/08/2026(105 days left)
Latest action published by the INPI: 03/31/2026. We update with every new RPI gazette, published weekly.
Applicants
KADMON CORPORATION, LLC
US
Inventors
A. V. (pessoa física)
FR
H. V. (pessoa física)
BE
K. B. (pessoa física)
US
M. M. (pessoa física)
FR
M. C. (pessoa física)
FR
M. B. (pessoa física)
US
IPC Classification
Priority claims
EP
23305096.2 · 01/26/2023
US
63/431,446 · 12/09/2022
Abstract
MÉTODOS DE ADMINISTRAÇÃO DE BELUMOSUDIL PARA TRATAMENTO DE MIELOMA MÚLTIPLO. A presente invenção refere-se a métodos para administrar belumosudil a pacientes com mieloma múltiplo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
03/31/2026
RPI 2882
#1.1
06/10/2025
RPI 2840
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.